“Advanced Therapeutics in Rheumatoid Arthritis (RA)”
This study will evaluate the retention rates of two advanced therapies, Tumour Necrosis Factor (TNF) and Janus kinase inhibitor (JAK) in the treatment of adults with Rheumatoid Arthritis (RA) over a two year period. It will also examine the ability to embed a clinical trial in a clinical situation using an electronic medical record (EMR).
Drug - Etanercept
Drug - tofacitinib
Advanced Therapeutics in Rheumatoid Arthritis (RA)